JAG2 can modulate the immunosuppressive microenvironment by potentially competing with DLL ligands for CD8+ T cells, or potentially increase Treg cell generation.38 Furthermore, how tumour-derived signals reprogram neutrophils into subsets of JAG2+TAN deserves further investigation. Here, CD8A is linked to neoplasm.